Teleflex Incorporated presented new clinical data at the 2025 American Urological Association Annual Meeting, highlighting the UroLift™ System as a leading minimally invasive treatment for benign ...
Teleflex announces favorable results for UroLift™ in treating BPH, showing higher patient satisfaction and better early recovery compared to Rezūm. Teleflex Incorporated announced new results from the ...
On Nov 16, we issued an updated research report on Teleflex Incorporated TFX. The company continues to report strong growth in UroLift. However, escalating costs and expenses remain a major cause of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback